The 20 Best Sezary Syndrome Doctors in The United States

Larisa Geskin is a Hematologist and a Dermatologist practicing medicine in New York, New York. Dr. Geskin is rated as an Elite provider by MediFind in the treatment of Sezary Syndrome. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Sezary Syndrome.

Christiane Querfeld is a Dermatologist practicing medicine in Duarte, California. Dr. Querfeld is rated as an Elite provider by MediFind in the treatment of Sezary Syndrome. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, and Sezary Syndrome.

Alain Rook is a Dermatologist practicing medicine in Philadelphia, Pennsylvania. Dr. Rook is rated as an Elite provider by MediFind in the treatment of Sezary Syndrome. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, and Sezary Syndrome. Dr. Rook is board certified in Dermatology, 1991, Nephrology, 1980, and Internal Medicine, 1979. Dr. Rook is currently accepting new patients.

Henry Wong is a Dermatologist practicing medicine in San Diego, California. Dr. Wong is rated as an Elite provider by MediFind in the treatment of Sezary Syndrome. He is also highly rated in 117 other conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Sezary Syndrome, and Mycosis Fungoides.

The T-cell lymphomas are a heterogeneous and poorly understood group of non-Hodgkin’s lymphomas. The most common T-cell lymphoma in the United States includes a heterogeneous mix of lymphomas that lack distinguishing characteristics and, until recently, remained clinically and molecularly “unspecified”. Improved understanding of T-cell lymphoma pathogenesis and the development of novel therapeutic strategies will be needed to address this challenge and improve outcomes for patients afflicted with these aggressive lymphomas. My group made the landmark discovery that the most common T-cell lymphoma in North America is comprised of two molecularly and clinically distinct subsets. This finding has significant implications for the classification and treatment of these lymphomas. We have also demonstrated that malignant T cells remain dependent upon antigen-presenting cells within the tumor microenvironment and are developing novel therapeutic strategies targeting these cells. Many fundamental questions, including the “cell of origin”, the role of antigen-, costimulatory-, and cytokine-receptor signaling, and the contribution of myeloid-derived antigen-presenting cells in disease pathogenesis remain obscure. My laboratory uses complementary mouse models and primary T-cell lymphoma specimens (in ex vivo and patient-derived xenograft studies) to address these fundamental and clinically relevant questions. We are poised to clinically translate our laboratory-based findings into novel therapeutic strategies that we hope will improve outcomes for patients afflicted with these aggressive lymphomas. I enjoy working with a multidisciplinary team of enthusiastic collaborators who share this common goal. Dr. Wilcox is rated as an Elite provider by MediFind in the treatment of Sezary Syndrome. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Wilcox is board certified in Internal Medicine, Hematology, and Medical Oncology.

Pierluigi Porcu is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Porcu is rated as an Elite provider by MediFind in the treatment of Sezary Syndrome. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, Bone Marrow Transplant, and Bone Marrow Aspiration.

Lubomir Sokol is a Hematologist and an Oncologist practicing medicine in Tampa, Florida. Dr. Sokol is rated as an Elite provider by MediFind in the treatment of Sezary Syndrome. He is also highly rated in 55 other conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Sokol is currently accepting new patients.

Jasmine Zain is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Zain is rated as an Elite provider by MediFind in the treatment of Sezary Syndrome. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Zain is currently accepting new patients.

Alison Moskowitz is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Moskowitz is rated as an Elite provider by MediFind in the treatment of Sezary Syndrome. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Moskowitz is currently accepting new patients.

Oleg Akilov is a Dermatologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Akilov is rated as a Distinguished provider by MediFind in the treatment of Sezary Syndrome. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, and Sezary Syndrome.

Joan Guitart is a Dermatologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 43 years. Dr. Guitart is rated as a Distinguished provider by MediFind in the treatment of Sezary Syndrome. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, and Lymphomatoid Papulosis. Dr. Guitart is board certified in American Board Of Dermatology - Dermatology (Certified).

I have two areas of clinical expertise: cutaneous lymphoma and hair disorders. In the area of cutaneous lymphoma, I have focused my research on clinical trials for new treatments and consensus building to establish standard guidelines for staging, evaluation, and treatment of patients, as well as the methodology used in clinical trials. My patients are invited to participate in my ongoing database, which captures their response to treatments. My goal is to find a cure for these cancers or, barring that, long lasting remissions. In the area of hair disorders, my goal is to help referring physicians diagnose and treat effectively multiple types of hair loss. My consultative practice is now focused on scarring alopecias, including frontal fibrosing alopecia and hair loss in African-American women in which causes are not obvious. My research focuses on collaborative work with multiple centers in the United States to help create knowledge and new treatments. Dr. Olsen is rated as a Distinguished provider by MediFind in the treatment of Sezary Syndrome. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, T-Cell Lymphoma, and Sezary Syndrome. Dr. Olsen is board certified in American Board Of Dermatology, Dermatology.

Pamela Allen is an Anesthesiologist practicing medicine in Atlanta, Georgia. She has been practicing medicine for over 5 years. Dr. Allen is rated as a Distinguished provider by MediFind in the treatment of Sezary Syndrome. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Allen is board certified in American Board Of Anesthesiology, 2025.

Dr. Tejasvi received his medical degree from Karnataka Institute of Medical Sciences, India. He completed residency-training program and worked as senior resident in Dermatology and Venereology, from All India Institute of Medical Sciences, New Delhi, India. He completed post-doctoral training in genetics of psoriasis under the direction of Drs. R.P.Nair and James T. Elder at the University of Michigan, Department of Dermatology in Ann Arbor.Dr. Tejasvi's primary research interest is translational genetics, epigenetics in psoriasis and pharmacogenetics that involves application of genetic information to predict response to therapies. Dr. Tejasvi is rated as a Distinguished provider by MediFind in the treatment of Sezary Syndrome. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis.

Stefan Barta is a Hematologist practicing medicine in Philadelphia, Pennsylvania. Dr. Barta is rated as a Distinguished provider by MediFind in the treatment of Sezary Syndrome. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, T-Cell Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Barta is board certified in Hematology, 2010 and Medical Oncology, 2010. Dr. Barta is currently accepting new patients.

Dean Tsarwhas is a Hematologist and an Oncologist practicing medicine in Lake Forest, Illinois. He has been practicing medicine for over 39 years. Dr. Tsarwhas is rated as a Distinguished provider by MediFind in the treatment of Sezary Syndrome. He is also highly rated in 58 other conditions, according to our data. His clinical expertise encompasses Sezary Syndrome, Paget Disease of the Breast, Angiosarcoma, and Large-Cell Immunoblastic Lymphoma. Dr. Tsarwhas is board certified in American Board Of Internal Medicine - Medical Oncology (Certified).

"Daniel J. Lewis, M.D. is a dual fellowship-trained Mohs and reconstructive surgeon and Assistant Professor of Dermatology at Johns Hopkins University School of Medicine. He leads the Mohs surgery unit at the Johns Hopkins Outpatient Center (JHOC), the hospital's flagship facility in downtown Baltimore. He is also heavily involved in education as the director of the JHOC resident surgery clinic and as core faculty for the Micrographic Surgery and Dermatologic Oncology fellowship. Dr. Lewis earned a B.A. in Biology from the University of Pennsylvania, earned his M.D. at Baylor College of Medicine while completing a research fellowship at The University of Texas MD Anderson Cancer Center, and completed his internship at Memorial Sloan Kettering Cancer Center. He then returned to Penn for dermatology residency, serving as chief resident at the country's No. 1-ranked dermatology program by Doximity. At Penn, he pursued further specialization with two year-long post-doctoral fellowships in cutaneous oncology and Mohs micrographic surgery. During his Mohs fellowship at Penn, Dr. Lewis worked at the largest academic Mohs surgery center in the country alongside leaders in the field and pioneers in the use of Mohs surgery with immunohistochemistry, complex reconstruction, high-risk tumors, and tumors on specialty sites. Dr. Lewis has authored over 90 peer-reviewed manuscripts in high-impact journals such as Journal of the American Academy of Dermatology, JAMA Dermatology, and Journal of Investigative Dermatology. He has also served on the Editorial Board of the International Journal of Dermatology and has authored multiple textbook chapters as well as two editions of the book Practical Ways to Improve Patient Adherence, named the winner of the 2022 ""Best Overall"" Dermie Award by Dermasphere. Dr. Lewis is an aspiring leader in cutaneous oncology and was named Post-Doctoral Trainee of the Year in 2022 by ADEN, winner of the 2022 ASDS Young Investigators Writing Competition, and a Rising Scholar by the Dermatology Foundation in 2023. He is a member of the Alpha Omega Alpha Honor Medical Society. He is passionate about Mohs micrographic surgery and has clinical interests in advanced facial reconstruction, Mohs surgery with immunohistochemistry, facial anatomy, Merkel cell carcinoma, melanoma, and patient adherence.". Dr. Lewis is rated as a Distinguished provider by MediFind in the treatment of Sezary Syndrome. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Sezary Syndrome. Dr. Lewis is board certified in American Board Of Dermatology.

Auris Huen is a Dermatologist practicing medicine in Cary, North Carolina. Dr. Huen is rated as a Distinguished provider by MediFind in the treatment of Sezary Syndrome. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Mycosis Fungoides, T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Lymphomatoid Papulosis, and Thymectomy.

Patricia Myskowski is a Dermatologist practicing medicine in New York, New York. Dr. Myskowski is rated as a Distinguished provider by MediFind in the treatment of Sezary Syndrome. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), and Lymphomatoid Papulosis.

John Zic is a Dermatologist practicing medicine in Nashville, Tennessee. Dr. Zic is rated as a Distinguished provider by MediFind in the treatment of Sezary Syndrome. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, and Sezary Syndrome.